Drug prices are steadily rising in Russia due to the weak rouble and the ever-growing prices for raw materials, most of which are traditionally imported to Russia from abroad, reports The Pharma Letter’s local correspondent.
The government expects that prices for drugs in the Russian market will grow by at least 8% this year, which will exceed the rate of inflation. This is, however, higher than initial expectations of authorities of 5%.
In the meantime, most of analysts consider even these forecasts as too optimistic, expecting a higher growth of prices, taking into account that the growth of drug prices shows the highest dynamics this year among the all non-food products in Russia, except only tobacco products.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze